Description
Supraphysiological Anabolic Response
LGD-3303 represents pharmaceutical-grade selective modulation—engineered not merely to restore muscle mass but to exceed natural physiological limits while maintaining exceptional tissue selectivity. This is anabolic chemistry designed for those who demand measurable tissue growth beyond baseline.
The Mechanism
LGD-3303 functions as a full agonist in skeletal muscle while operating as a partial agonist in androgenic tissues like the prostate and preputial gland. This differential activation pattern means the selectivity occurs at the receptor level through altered molecular interactions with the androgen receptor itself. With potent AR binding and excellent oral bioavailability, LGD-3303 reaches peak activity rapidly, driving protein synthesis and nitrogen retention in muscle tissue while maintaining prostate weight at or below 50% of natural levels.
Anabolic Capacity
LGD-3303’s ability to increase muscle mass above natural levels—a defining characteristic separating it from mere restoration compounds, doesn’t simply preserve muscle it actively builds tissue beyond what natural testosterone production achieves. Simultaneously, LGD-3303 exhibits profound effects on bone mineral density while fat reduction occurs concurrently.
LGD-3303 is receptor level tissue technology —
There are no reviews yet.